MIMEDX GROUP INC (MDXG)

US6024961012 - Common Stock

6.27  +0.02 (+0.4%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
258.6M
4.19%		267.8M
3.56%		321.477M
20.04%		364.26M
13.31%
EBITDA
YoY % growth
3.98M
-81.87%		-8.75M
-319.85%		45.719M
622.50%		74.8M
63.61%		N/AN/A
EBIT
YoY % growth
-1.2M
-107.95%		-12.8M
-966.67%		42.292M
430.41%		57.6M
36.20%
Operating Margin
-0.46%-4.78%13.16%15.81%
EPS
YoY % growth
-0.15-0.33
-120.00%		0.32
196.97%		0.31
-1.83%		N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		0.05
176.50%
Revenue
Q2Q % growth		80.948M
12.93%
EBITDA
Q2Q % growth		14.948M
EBIT
Q2Q % growth		8.841M
2,948.62%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 0.32
1,700.00%		0.070.25348.18%
Q3 2023
Q2Q % growth		 0.06
166.67%		0.050.0130.72%
Q2 2023
Q2Q % growth		 0.00
100.00%		-0.020.02100.00%
Q1 2023
Q2Q % growth		 -0.06
45.45%		-0.090.0332.13%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 86.832M
16.74%		86.751M81K0.09%
Q3 2023
Q2Q % growth		 81.71M
20.71%		79.496M2.214M2.79%
Q2 2023
Q2Q % growth		 81.26M
21.50%		76.322M4.938M6.47%
Q1 2023
Q2Q % growth		 71.68M
21.72%		65.433M6.247M9.55%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 22.72% -1.44% -2.22%
Revenue0% -1.34% -0.13% 0.38%